<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">zdor</journal-id><journal-title-group><journal-title xml:lang="ru">Проблемы здоровья и экологии</journal-title><trans-title-group xml:lang="en"><trans-title>Health and Ecology Issues</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2220-0967</issn><issn pub-type="epub">2708-6011</issn><publisher><publisher-name>Gomel State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.51523/2708-6011.2019-16-4-3</article-id><article-id custom-type="elpub" pub-id-type="custom">zdor-148</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКАЯ МЕДИЦИНА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL MEDICINE</subject></subj-group></article-categories><title-group><article-title>Особенности течения и исходов ВИЧ-инфекции, диагностированной на стадии выраженной иммуносупрессии</article-title><trans-title-group xml:lang="en"><trans-title>The Features of the Course and Outcomes of HIV Infection Diagnosed at the Stage of Pronounced Immunosuppression</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Матиевская</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Matsiyeuskaya</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Матиевская Н.В., д.м.н., доцент, заведующий кафедрой инфекционных болезней Учреждения образования «Гродненский государственный медицинский университет».</p></bio><bio xml:lang="en"><p>Matsiyeuskaya N.V., MD, PhD, Head of the Department of Infectious Diseases of the educational institution «Grodno State Medical University».</p></bio><email xlink:type="simple">natamati@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Учреждение образования «Гродненский государственный медицинский университет»</institution></aff><aff xml:lang="en"><institution>Grodno State Medical University</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>28</day><month>12</month><year>2019</year></pub-date><volume>0</volume><issue>4</issue><fpage>16</fpage><lpage>22</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Матиевская Н.В., 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Матиевская Н.В.</copyright-holder><copyright-holder xml:lang="en">Matsiyeuskaya N.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.gsmu.by/jour/article/view/148">https://journal.gsmu.by/jour/article/view/148</self-uri><abstract><sec><title>Цель</title><p>Цель: представить особенности течения и исходов ВИЧ-инфекции, диагностированной на стадии выраженной иммуносупрессии.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. 492 пациента, живущих с ВИЧ, исходя из первичного показателя CD4+T-лимфоцитов были разделены на 2 группы: группа 1 - 220 пациентов (CD4+TЛ менее или равен 350 кл/мкл), группа 2 - 272 пациента (CD4+TЛ более 350 кл/мкл). Статистический анализ выполнялся с использованием пакета «Statistica», 10.</p></sec><sec><title>Результаты</title><p>Результаты. Среди пациентов 1-й группы было больше мужчин, чем во 2-й группе: 136 (61,8 %) и 125 (46 %) (p &lt; 0,001) соответственно; пациентов, находящихся на 3-й и 4-й клинических стадиях ВИЧ-инфекции - 52,7 и 27,6 % (p &lt; 0,05); пациентов на АРТ: 208 (94,5 %) и 148 (54,4 %) (p &lt; 0,001) соответственно. Показатели Т-хелперов и ИРИ (иммунорегуляторный индекс) у пациентов группы 2 в динамике наблюдения сохранялись значительно более высокими по сравнению с аналогичными показателями пациентов группы 1. Частота туберкулеза была выше в 1-й группе: 33 (15 %) и 15 (5,5 %) соответственно (p &lt; 0,05). В 1-й группе умерли 23 (10,5 %) пациента, во 2-й - 9 (3,3 %) (p &lt; 0,003).</p></sec><sec><title>Заключение</title><p>Заключение. ВИЧ-инфекция на стадии выраженной иммуносупрессии диагностирована у 220 пациентов - 44,7 % (95 % ДИ: 40,4-49,1) случаев. Выраженная иммуносупрессия у пациентов с первично выявленным заболеванием ассоциировалась с наличием 3-й и 4-й клинических стадий ВИЧ-инфекции (OR - 2,9; 95 % ДИ 2,0-4,3), более высокой частотой туберкулеза (OR - 3,02; 95 % ДИ: 1,6-5,7) и летальных исходов (OR - 3,4; 95 % ДИ 1,5-7,5), более медленным приростом Т-хелперов и ИРИ.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Objective</title><p>Objective: to present the features of the course and outcomes of HIV infection diagnosed at the stage of pronounced immunosuppression.</p></sec><sec><title>Material and methods</title><p>Material and methods. Based on the primary CD4 + T-lymphocytes count, 492 patients living with HIV were divided into 2 groups: group 1 - 220 patients (CD4 + TL less than or equal to 350 cells/μl), group 2 - 272 patients (CD4 + TL more than 350 cells/µl). The statistical analysis was performed using the package «Statisticа» v.10.</p></sec><sec><title>Results</title><p>Results. Among the patients of the first group there were more men than in the second group: 136 (61.8 %) and 125 (46 %), p &lt; 0.001, respectively; more patients in HIV clinical stages 3 and 4 - 52.7 % and 27.6 %, p &lt; 0.05; more ART patients: 208 (94.5 %) and 148 (54.4 %) p &lt; 0.001, respectively. The levels of T-helpers and IRI (immunoregulatory index) in the patients of group 2 in the follow-up dynamics remained significantly higher compared with those of the patients of group 1. The incidence of tuberculosis was higher in group 1: 33 (15 %) and 15 (5.5 %), respectively, p &lt; 0.05. In the first group, 23 (10.5 %) patients died, in the second - 9 (3.3 %), p &lt; 0.003.</p></sec><sec><title>Conclusion</title><p>Conclusion. HIV-infection at the stage of pronounced immunosuppression was diagnosed in 220 patients - 44.7 % (95 % CI: 40.4-49.1) of the cases. Severe immunosuppression in the primarily diagnosed patients was associated with the presence of HIV clinical stages 3 and 4 (OR - 2.9; 95 % CI: 2.0-4.3), higher incidence rates of tuberculosis (OR - 3.02; 95 % CI: 1.6-5.7) and fatal outcomes (OR - 3.4; 95 % CI: 1.5-7.5), a slower increase in T-helpers and IRI counts.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>ВИЧ-инфекция</kwd><kwd>поздняя диагностика</kwd><kwd>иммуносупрессия</kwd><kwd>летальность</kwd></kwd-group><kwd-group xml:lang="en"><kwd>HIV infection</kwd><kwd>late diagnosis</kwd><kwd>immunosuppression</kwd><kwd>mortality</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">HIV/AIDS surveillance in Europe 2017 - 2016 data [Electronic resource]. Available from: https://www.ecdc.europa.eu/en/ publications-data/hivaids-surveillance-europe-2017-2016-data.</mixed-citation><mixed-citation xml:lang="en">HIV/AIDS surveillance in Europe 2017 - 2016 data [Electronic resource]. Available from: https://www.ecdc.europa.eu/en/ publications-data/hivaids-surveillance-europe-2017-2016-data.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Cuzin L, Yazdanpanah Y, Huleux T, Cotte L, Pugliese P, Allavena C et al. Dat'AIDS Study Group No relationship between late HIV diagnosis and social deprivation in newly diagnosed patients in France. HIV Med. 2018;Mar;19(3):238-42. doi:10.1111/hiv.12545.Epub 2017Aug18.</mixed-citation><mixed-citation xml:lang="en">Cuzin L, Yazdanpanah Y, Huleux T, Cotte L, Pugliese P, Allavena C et al. Dat'AIDS Study Group No relationship between late HIV diagnosis and social deprivation in newly diagnosed patients in France. HIV Med. 2018;Mar;19(3):238-42. doi:10.1111/hiv.12545.Epub 2017Aug18.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Noble G, Okpo E, Tonna I, &amp; Fielding S. Factors associated with late HIV diagnosis in North-East Scotland: a six-year retrospective study. Public Health. 2016;139:36-43. https://doi.org/10.1016/ j.puhe.2016.06.007.</mixed-citation><mixed-citation xml:lang="en">Noble G, Okpo E, Tonna I, &amp; Fielding S. Factors associated with late HIV diagnosis in North-East Scotland: a six-year retrospective study. Public Health. 2016;139:36-43. https://doi.org/10.1016/ j.puhe.2016.06.007.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Darling KEA., Hachfel A, Cavassini M, Kirk O, Furrer H, Wandeler G. Late presentation to HIV care despite good access to health services: current epidemiological trends and how to do better. Swiss Med Wkly. 2016;146:w14348. doi:10.4414/smw.2016.14348.</mixed-citation><mixed-citation xml:lang="en">Darling KEA., Hachfel A, Cavassini M, Kirk O, Furrer H, Wandeler G. Late presentation to HIV care despite good access to health services: current epidemiological trends and how to do better. Swiss Med Wkly. 2016;146:w14348. doi:10.4414/smw.2016.14348.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Celesia BM., Castronuovo D, Pinzone MR., Bellissimo F, Mughini MT, Lupo G, et al. Late presentation of HIV infection: predictors of delayed diagnosis and survival in Eastern Sicily. European Review for Medical and Pharmacological Sciences 2013;17:2218-24.</mixed-citation><mixed-citation xml:lang="en">Celesia BM., Castronuovo D, Pinzone MR., Bellissimo F, Mughini MT, Lupo G, et al. Late presentation of HIV infection: predictors of delayed diagnosis and survival in Eastern Sicily. European Review for Medical and Pharmacological Sciences 2013;17:2218-24.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Mocroft A, Lundgren JD, Sabin ML, Monforte A, Brockmeyer N, Casabona J, et al. Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE). PLoSMed. 2013;10:e1001510.</mixed-citation><mixed-citation xml:lang="en">Mocroft A, Lundgren JD, Sabin ML, Monforte A, Brockmeyer N, Casabona J, et al. Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE). PLoSMed. 2013;10:e1001510.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Fuster-Ruiz de Apodacaa MJ., Molerob F, Nouvilasb E, Arazob P, Dalmau D. Determinants of late diagnosis of HIV infection in Spain. Psychosocial Intervention. 2014;23:177-85.</mixed-citation><mixed-citation xml:lang="en">Fuster-Ruiz de Apodacaa MJ., Molerob F, Nouvilasb E, Arazob P, Dalmau D. Determinants of late diagnosis of HIV infection in Spain. Psychosocial Intervention. 2014;23:177-85.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">MacCarthy S, Brignol S, Reddy M, Nunn A, Dourado I. Making the invisible, visible: a cross-sectional study of late presentation to HIV/AIDS services among men who have sex with men from a large urban center of Brazil. BMC Public Health. 2014;14:1313. doi:10.1186/1471-2458-14-1313.</mixed-citation><mixed-citation xml:lang="en">MacCarthy S, Brignol S, Reddy M, Nunn A, Dourado I. Making the invisible, visible: a cross-sectional study of late presentation to HIV/AIDS services among men who have sex with men from a large urban center of Brazil. BMC Public Health. 2014;14:1313. doi:10.1186/1471-2458-14-1313.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Панкова ЕД., Никульшина ЛЛ. Поздняя диагностика ВИЧ-инфекции у молодого пациента. Клинический случай. Вестник СМУС74. 2018;2(21). URL: https://cyberleninka.ru/article /n/pozdnyaya-diagnostika-vich-infektsii-u-molodogo-patsienta-klini-cheskiy-sluchay.</mixed-citation><mixed-citation xml:lang="en">Панкова ЕД., Никульшина ЛЛ. Поздняя диагностика ВИЧ-инфекции у молодого пациента. Клинический случай. Вестник СМУС74. 2018;2(21). URL: https://cyberleninka.ru/article /n/pozdnyaya-diagnostika-vich-infektsii-u-molodogo-patsienta-klini-cheskiy-sluchay.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Матиевская НВ. Ко-инфекция ВИЧ/ВГС: этиология, эпидемиология, патогенез, клиника, диагностика, лечение: монография. Гродно, Беларусь: ГрГМУ; 2013. 352 с.</mixed-citation><mixed-citation xml:lang="en">Матиевская НВ. Ко-инфекция ВИЧ/ВГС: этиология, эпидемиология, патогенез, клиника, диагностика, лечение: монография. Гродно, Беларусь: ГрГМУ; 2013. 352 с.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Raben D, Sullivan AK, Mocroft A, Kutsyna G, Hadžiosmanović V, Vassilenko A, Chkhartisvili N, Mitsura V. et al. Improving the evidence for indicator condition guided HIV testing in Europe: results from the HIDES II study – 2012-2015 PLoS One. 2019;14(8): e0220108. doi:10.1371/journal.pone.0220108.</mixed-citation><mixed-citation xml:lang="en">Raben D, Sullivan AK, Mocroft A, Kutsyna G, Hadžiosmanović V, Vassilenko A, Chkhartisvili N, Mitsura V. et al. Improving the evidence for indicator condition guided HIV testing in Europe: results from the HIDES II study – 2012-2015 PLoS One. 2019;14(8): e0220108. doi:10.1371/journal.pone.0220108.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
